Pristimerin Protects Against OVX-Mediated Bone Loss by Attenuating Osteoclast Formation and Activity via Inhibition of RANKL-Mediated Activation of NF-κB and ERK Signaling Pathways

Samankaltaisia teoksia

• Sesamolin Protects Mice From Ovariectomized Bone Loss by Inhibiting Osteoclastogenesis and RANKL-Mediated NF-κB and MAPK Signaling Pathways
  Tekijä: Yang, Xue, et al.
  Julkaistu: (2021)
• Amyloid β Peptide Enhances RANKL-Induced Osteoclast Activation through NF-κB, ERK, and Calcium Oscillation Signaling
  Tekijä: Li, Shangfu, et al.
  Julkaistu: (2016)
• Mutation in Osteoactivin Promotes Receptor Activator of NFκB Ligand (RANKL)-mediated Osteoclast Differentiation and Survival but Inhibits Osteoclast Function
  Tekijä: Abdelmagid, Samir M., et al.
  Julkaistu: (2015)
• Reciprocal Role of ERK and Nf-κb Pathways in Survival and Activation of Osteoclasts
  Tekijä: Miyazaki, Tsuyoshi, et al.
  Julkaistu: (2000)
• Berberine Sulfate Attenuates Osteoclast Differentiation through RANKL Induced NF-κB and NFAT Pathways
  Tekijä: Zhou, Lin, et al.
  Julkaistu: (2015)